Past research has subtyped patients with Myalgic Encephalomyelitis (ME)
and Chronic Fatigue Syndrome (CFS) according to factors related to illness
onset, illness duration, and age. However, no classification system fully
accounts for the wide range of symptom severity, functional disability,
progression, and prognosis seen among patients. This study examined whether
illness trajectories among individuals with CFS were predictive of different
levels of symptomology, functional disability, and energy expenditure. Of the
participants (N=541), the majority described their
illness as Fluctuating (59.7%), with 15.9% Constantly Getting
Worse, 14.1% Persisting, 8.5% Relapsing and Remitting, and
1.9% Constantly Getting Better. The illness courses were associated with
significant differences in symptomology on select domains of the DSQ,
functioning on select subscales of the SF-36, and on overall levels of energy
expenditure. The significant symptomatic and functional differences between
groups suggest that subtyping patients with CFS according to illness course is a
promising method for creating more homogeneous groups of patients.